Skip to main content
logo
SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.790
+0.220 (6.16%)
At close: Aug 3, 2026, 4:00 PM EDT
3.700
-0.090 (-2.37%)
After-hours: Aug 3, 2026, 7:34 PM EDT

SAB Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
290178356330340
Market Cap Growth
1280.05%405.79%-44.53%113.51%-91.25%-
Enterprise Value
175.5887.4219.1112.8120.61304.84
Last Close Price
3.793.743.796.885.9078.10

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--26.6228.351.245.58
PB Ratio
1.191.181.361.110.96-
P/TBV Ratio
1.231.511.350.660.83-
P/OCF Ratio
-----170.94

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--14.455.720.865.01

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.030.160.090.17-
Net Debt / Equity Ratio
-0.44-0.60-0.62-0.88-0.29-
Net Debt / EBITDA Ratio
1.841.980.421.480.362.96
Net Debt / FCF Ratio
1.981.980.472.000.363.88
Asset Turnover
-00.020.030.360.88
Quick Ratio
11.069.132.615.231.371.80
Current Ratio
11.459.462.985.451.471.90
Return on Equity (ROE)
-0.21%14.96%-81.92%-95.51%-120.35%-
Return on Assets (ROA)
-27.62%-45.12%-66.98%-56.47%-43.74%-19.46%
Return on Invested Capital (ROIC)
-62.26%-138.42%-519.55%-266.44%-131.62%-
Return on Capital Employed (ROCE)
-29.04%-49.36%-78.49%-69.84%-63.84%-26.74%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-227.56%-562.28%-67.74%-26.86%-59.20%-1.21%
Total Shareholder Return
-227.56%-562.28%-67.74%-26.86%-59.20%-1.21%
SEC Filings: 10-K · 10-Q